Next Article in Journal
Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto’s Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report
Next Article in Special Issue
Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac® in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa
Previous Article in Journal
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
Previous Article in Special Issue
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)
 
 
Article

Article Versions Notes

Vaccines 2022, 10(3), 449; https://doi.org/10.3390/vaccines10030449
Action Date Notes Link
article xml file uploaded 15 March 2022 03:16 CET Original file -
article xml uploaded. 15 March 2022 03:16 CET Update https://www.mdpi.com/2076-393X/10/3/449/xml
article pdf uploaded. 15 March 2022 03:16 CET Version of Record https://www.mdpi.com/2076-393X/10/3/449/pdf
article supplementary file uploaded. 15 March 2022 03:16 CET - https://www.mdpi.com/2076-393X/10/3/449#supplementary
article html file updated 15 March 2022 03:17 CET Original file -
article html file updated 1 August 2022 05:41 CEST Update https://www.mdpi.com/2076-393X/10/3/449/html
Back to TopTop